Table 2.
Clinical characteristics of patients with basal cell neoplasms
| |
|
BCACs |
BCAs with ci. |
BCAs without ci. |
|---|---|---|---|---|
| (n=8) | (n=11) | (n=10) | ||
| Age (yrs) |
Mean (range) |
61 (51–79) |
48 (27–67) |
48 (27–64) |
| Sex |
Female/Male |
6/2 |
8/3 |
9/1 |
| Tumor size (cm) |
Mean (range) |
3.5 (1.6–5.0) |
3.1 (1.8–7.5) |
1.9 (1.3–2.5) |
| Site |
Parotid gland (Lt/Rt) |
8 (6/2) |
11 (9/2) |
9 (5/4) |
| |
Submandibular gland |
0 |
0 |
1 |
| Treatment |
Surgery |
3 |
4 |
10 |
| Surgery + RT |
5 |
7 |
0 |
|
| Follow-up |
Recurrence |
0 |
0 |
0 |
| NED |
6 |
7 |
10 |
|
| Loss | 2 | 4 | 0 |
BCAC, basal cell adenocarcinoma; BCA, basal cell adenoma; ci., capsular invasion; Lt, left; NED, no evidence of disease; Rt, right; RT, radiotherapy.